This book investigates the pharmacological mechanisms and clinical optimization of inhaled glucocorticoids as the primary prophylactic treatment for asthma. Author Ralph Brattsand synthesizes historical development with modern kinetic data to explain how these medications achieve airway selectivity. The text provides a comprehensive framework for understanding how localized drug delivery minimizes systemic side effects while maximizing therapeutic efficacy in the respiratory tract.

Experts recognize this work as a technical resource for understanding the pharmacodynamics of asthma management. The text is noted for its dense, clinical focus on the specific interactions between inhaled steroids and airway tissue.